Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse

Abstract Background Prescription opioids (POs) are commonly used to treat moderate to severe chronic pain in the health system setting. Although they improve quality of life for many patients, more work is needed to identify both the clinical and genetic factors that put certain individuals at high...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Vanessa Troiani, Richard C. Crist, Glenn A. Doyle, Thomas N. Ferraro, Donielle Beiler, Stephanie Ranck, Kortney McBryan, Margaret A. Jarvis, Jordan S. Barbour, John J. Han, Ryan J. Ness, Wade H. Berrettini, Janet D. Robishaw
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-10-01
coleção:	BMC Medical Genomics
Assuntos:	Opioid use disorder (OUD) Genetics Addiction Substance misuse
Acesso em linha:	https://doi.org/10.1186/s12920-021-01100-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!